Combination of TATE and PD-1 Inhibitor in Liver Cancer

Clinical trial NCT03259867 · RECRUITING

Trial details

NCT number: NCT03259867
Sponsor: Teclison Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Gastric Cancer

Start date: 2017-07-01
Primary completion: 2026-12-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.